Cargando…

Preference of individuals in the treatment strategies of acute myocardial infarction in China: a discrete choice experiment

BACKGROUND: Acute myocardial infarction (AMI) is a significant cause of mortality and morbidity worldwide. Today, with increasing life quality and social economy, people pay much attention to the cost-effectiveness of a treatment strategy. This study investigated the preferences of individuals who w...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Weiqian, Liu, Chang, Liu, Jiahe, Lin, Yaduan, Cheng, Yu, Ming, Wai-kit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339539/
https://www.ncbi.nlm.nih.gov/pubmed/32635917
http://dx.doi.org/10.1186/s12955-020-01466-1
_version_ 1783554912972439552
author Dai, Weiqian
Liu, Chang
Liu, Jiahe
Lin, Yaduan
Cheng, Yu
Ming, Wai-kit
author_facet Dai, Weiqian
Liu, Chang
Liu, Jiahe
Lin, Yaduan
Cheng, Yu
Ming, Wai-kit
author_sort Dai, Weiqian
collection PubMed
description BACKGROUND: Acute myocardial infarction (AMI) is a significant cause of mortality and morbidity worldwide. Today, with increasing life quality and social economy, people pay much attention to the cost-effectiveness of a treatment strategy. This study investigated the preferences of individuals who would be potential caregivers or patients for AMI treatment in order to provide liable and instructive information for cardiologists and other related physicians. METHODS: A discrete choice experiment was conducted among people to assess preferences for hypothetical AMI treatment scenarios characterized by the attributes of treatment method, mortality within 5 years, complication rate within 1 year, treatment duration and expense. A conditional logit regression model and latent class analysis were used to interpret the collected data systematically. The relative importance of each attribute and willingness to pay of people on the trade-offs between different treatment strategies were estimated. RESULTS: Participants valued mortality within 5 years most highly (average importance: 40.9, 95%CI 0.447–0.530). Three classes of participants were identified: Class 1 placed the most importance on treatment duration, class 2 corresponded with the overall result while expense was regarded as the most important attribute in class 3. Individuals favored an intermediate treatment duration of about 10 days instead of the shortest (95% CI 1.044–1.248, P < 0.001). People’s characteristics (sex, age, marriage, education and income) affected their preferences (P < 0.01). CONCLUSION: People considered a mortality rate within 5 years as the most crucial attribute in the MI treatment and preferred an intermediate treatment duration of about 10 days. Furthermore, the findings estimated the trade-offs acceptable to patients and heterogeneity in preferences for AMI treatment.
format Online
Article
Text
id pubmed-7339539
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73395392020-07-09 Preference of individuals in the treatment strategies of acute myocardial infarction in China: a discrete choice experiment Dai, Weiqian Liu, Chang Liu, Jiahe Lin, Yaduan Cheng, Yu Ming, Wai-kit Health Qual Life Outcomes Research BACKGROUND: Acute myocardial infarction (AMI) is a significant cause of mortality and morbidity worldwide. Today, with increasing life quality and social economy, people pay much attention to the cost-effectiveness of a treatment strategy. This study investigated the preferences of individuals who would be potential caregivers or patients for AMI treatment in order to provide liable and instructive information for cardiologists and other related physicians. METHODS: A discrete choice experiment was conducted among people to assess preferences for hypothetical AMI treatment scenarios characterized by the attributes of treatment method, mortality within 5 years, complication rate within 1 year, treatment duration and expense. A conditional logit regression model and latent class analysis were used to interpret the collected data systematically. The relative importance of each attribute and willingness to pay of people on the trade-offs between different treatment strategies were estimated. RESULTS: Participants valued mortality within 5 years most highly (average importance: 40.9, 95%CI 0.447–0.530). Three classes of participants were identified: Class 1 placed the most importance on treatment duration, class 2 corresponded with the overall result while expense was regarded as the most important attribute in class 3. Individuals favored an intermediate treatment duration of about 10 days instead of the shortest (95% CI 1.044–1.248, P < 0.001). People’s characteristics (sex, age, marriage, education and income) affected their preferences (P < 0.01). CONCLUSION: People considered a mortality rate within 5 years as the most crucial attribute in the MI treatment and preferred an intermediate treatment duration of about 10 days. Furthermore, the findings estimated the trade-offs acceptable to patients and heterogeneity in preferences for AMI treatment. BioMed Central 2020-07-07 /pmc/articles/PMC7339539/ /pubmed/32635917 http://dx.doi.org/10.1186/s12955-020-01466-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Dai, Weiqian
Liu, Chang
Liu, Jiahe
Lin, Yaduan
Cheng, Yu
Ming, Wai-kit
Preference of individuals in the treatment strategies of acute myocardial infarction in China: a discrete choice experiment
title Preference of individuals in the treatment strategies of acute myocardial infarction in China: a discrete choice experiment
title_full Preference of individuals in the treatment strategies of acute myocardial infarction in China: a discrete choice experiment
title_fullStr Preference of individuals in the treatment strategies of acute myocardial infarction in China: a discrete choice experiment
title_full_unstemmed Preference of individuals in the treatment strategies of acute myocardial infarction in China: a discrete choice experiment
title_short Preference of individuals in the treatment strategies of acute myocardial infarction in China: a discrete choice experiment
title_sort preference of individuals in the treatment strategies of acute myocardial infarction in china: a discrete choice experiment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339539/
https://www.ncbi.nlm.nih.gov/pubmed/32635917
http://dx.doi.org/10.1186/s12955-020-01466-1
work_keys_str_mv AT daiweiqian preferenceofindividualsinthetreatmentstrategiesofacutemyocardialinfarctioninchinaadiscretechoiceexperiment
AT liuchang preferenceofindividualsinthetreatmentstrategiesofacutemyocardialinfarctioninchinaadiscretechoiceexperiment
AT liujiahe preferenceofindividualsinthetreatmentstrategiesofacutemyocardialinfarctioninchinaadiscretechoiceexperiment
AT linyaduan preferenceofindividualsinthetreatmentstrategiesofacutemyocardialinfarctioninchinaadiscretechoiceexperiment
AT chengyu preferenceofindividualsinthetreatmentstrategiesofacutemyocardialinfarctioninchinaadiscretechoiceexperiment
AT mingwaikit preferenceofindividualsinthetreatmentstrategiesofacutemyocardialinfarctioninchinaadiscretechoiceexperiment